Strategic Wealth Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$247K Sell
6,314
-3,218
-34% -$125K 0.09% 109
2021
Q1
$345K Buy
9,532
+463
+5% +$16.4K 0.13% 92
2020
Q4
$334K Buy
9,069
+1,526
+20% +$56K 0.14% 81
2020
Q3
$263K Sell
7,543
-2,472
-25% -$86.7K 0.13% 91
2020
Q2
$311K Buy
10,015
+3,492
+54% +$119K 0.18% 65
2020
Q1
$202K Sell
6,523
-1,363
-17% -$46.4K 0.15% 78
2019
Q4
$293K Buy
+7,886
New +$281K 0.19% 69
2019
Q3
Sell
-5,825
Closed -$239K 87
2019
Q2
$239K Sell
5,825
-927
-14% -$36.8K 0.18% 68
2019
Q1
$272K Buy
6,752
+635
+10% +$25.4K 0.22% 62
2018
Q4
$253K Buy
+6,117
New +$254K 0.24% 63

Other funds holding PFE

Strategic Wealth Management Group's PFE Position: Q2 2021 in Review

Strategic Wealth Management Group reduced its Pfizer (PFE) stake by 34% in Q2 2021, selling an estimated $125K and leaving 6,314 shares worth $247K. The position accounts for 0.09% of the portfolio, ranked #109.

Strategic Wealth Management Group first reported a position in PFE in Q4 2018 and has held it in 10 quarters since. The position peaked at $345K in Q1 2021. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • Strategic Wealth Management Group held 6,314 shares of Pfizer worth $247K as of Q2 2021.
  • Strategic Wealth Management Group sold 3,218 Pfizer shares in Q2 2021, an estimated $125K.
  • Pfizer made up 0.09% of Strategic Wealth Management Group's portfolio in Q2 2021, its #109 holding.
  • Strategic Wealth Management Group first reported a position in Pfizer in Q4 2018 and has held it in 10 quarters since.
  • Strategic Wealth Management Group's Pfizer position peaked at $345K in Q1 2021.
  • 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Strategic Wealth Management Group's 13F filing for Q2 2021, filed 13 Aug 2021.